| SC 13G/A | 2023-02-10 | Flynn James E | AERIE PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2022-11-10 | MORGAN STANLEY | AERIE PHARMACEUTICALS INC | 384,245 | 0.8% | EDGAR |
| SC 13G/A | 2022-02-14 | PFM Health Sciences, LP | AERIE PHARMACEUTICALS INC | - | 2.3% | EDGAR |
| SC 13G/A | 2022-02-11 | Flynn James E | AERIE PHARMACEUTICALS INC | 4,200,804 | 8.9% | EDGAR |
| SC 13G/A | 2022-02-09 | VANGUARD GROUP INC | AERIE PHARMACEUTICALS INC | 3,381,368 | 7.1% | EDGAR |
| SC 13G | 2022-02-09 | MORGAN STANLEY | AERIE PHARMACEUTICALS INC | 4,070,392 | 8.6% | EDGAR |
| SC 13G/A | 2022-02-03 | BlackRock Inc. | AERIE PHARMACEUTICALS INC | 3,386,015 | 7.1% | EDGAR |
| SC 13G | 2021-08-16 | Flynn James E | AERIE PHARMACEUTICALS INC | 2,041,285 | 4.3% | EDGAR |
| SC 13G/A | 2021-02-16 | PFM Health Sciences, LP | AERIE PHARMACEUTICALS INC | - | 6.0% | EDGAR |
| SC 13G/A | 2021-02-10 | VANGUARD GROUP INC | AERIE PHARMACEUTICALS INC | 4,217,071 | 9.0% | EDGAR |
| SC 13G | 2021-02-09 | HARTFORD MUTUAL FUNDS INC/CT | AERIE PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-02-05 | BlackRock Inc. | AERIE PHARMACEUTICALS INC | 3,892,241 | 8.3% | EDGAR |
| SC 13G/A | 2020-07-09 | WELLINGTON MANAGEMENT GROUP LLP | AERIE PHARMACEUTICALS INC | 1,194,841 | 2.6% | EDGAR |
| SC 13G/A | 2020-06-30 | Flynn James E | AERIE PHARMACEUTICALS INC | 0 | 0.0% | EDGAR |
| SC 13G/A | 2020-06-12 | Foresite Capital Fund II, L.P. | AERIE PHARMACEUTICALS INC | 253,698 | 0.5% | EDGAR |
| SC 13G/A | 2020-06-09 | WELLINGTON MANAGEMENT GROUP LLP | AERIE PHARMACEUTICALS INC | 4,291,200 | 9.2% | EDGAR |
| SC 13G | 2020-03-24 | Flynn James E | AERIE PHARMACEUTICALS INC | 2,037,931 | 4.4% | EDGAR |
| SC 13G/A | 2020-02-14 | Foresite Capital Fund II, L.P. | AERIE PHARMACEUTICALS INC | 1,672,714 | 3.6% | EDGAR |
| SC 13G/A | 2020-02-14 | HARTFORD MUTUAL FUNDS INC/CT | AERIE PHARMACEUTICALS INC | 2,597,265 | 5.6% | EDGAR |
| SC 13G/A | 2020-02-14 | Partner Fund Management, L.P. | AERIE PHARMACEUTICALS INC | - | 5.2% | EDGAR |